Executive officer

Maria (Cecilia) Soriano

Group President, Infusion Therapies & Technologies (ITT) and Pharmaceuticals·Baxter International Inc.

About

M

a

r

i

a

C

e

c

i

l

i

a

S

o

r

i

a

n

o

i

s

G

r

o

u

p

P

r

e

s

i

d

e

n

t

,

I

n

f

u

s

i

o

n

T

h

e

r

a

p

i

e

s

&

T

e

c

h

n

o

l

o

g

i

e

s

&

P

h

a

r

m

a

c

e

u

t

i

c

a

l

s

a

t

B

a

x

t

e

r

I

n

t

e

r

n

a

t

i

o

n

a

l

.

S

h

e

w

a

s

a

p

p

o

i

n

t

e

d

t

o

h

e

r

c

u

r

r

e

n

t

r

o

l

e

i

n

2

0

2

5

a

f

t

e

r

s

e

r

v

i

n

g

a

s

P

r

e

s

i

d

e

n

t

,

I

n

f

u

s

i

o

n

T

h

e

r

a

p

i

e

s

&

T

e

c

h

n

o

l

o

g

i

e

s

s

i

n

c

e

2

0

2

3

.

P

r

i

o

r

t

o

j

o

i

n

i

n

g

B

a

x

t

e

r

,

M

s

.

S

o

r

i

a

n

o

s

e

r

v

e

d

i

n

r

o

l

e

s

o

f

i

n

c

r

e

a

s

i

n

g

r

e

s

p

o

n

s

i

b

i

l

i

t

y

a

t

B

e

c

t

o

n

,

D

i

c

k

i

n

s

o

n

a

n

d

C

o

m

p

a

n

y

,

i

n

c

l

u

d

i

n

g

a

s

G

l

o

b

a

l

V

i

c

e

P

r

e

s

i

d

e

n

t

a

n

d

G

e

n

e

r

a

l

M

a

n

a

g

e

r

,

M

i

c

r

o

b

i

o

l

o

g

y

f

r

o

m

2

0

2

0

t

o

2

0

2

3

;

U

.

S

.

V

i

c

e

P

r

e

s

i

d

e

n

t

a

n

d

G

e

n

e

r

a

l

M

a

n

a

g

e

r

,

D

i

a

b

e

t

e

s

C

a

r

e

;

S

e

n

i

o

r

V

i

c

e

P

r

e

s

i

d

e

n

t

,

G

l

o

b

a

l

M

a

r

k

e

t

i

n

g

a

n

d

S

t

r

a

t

e

g

y

;

a

n

d

V

i

c

e

P

r

e

s

i

d

e

n

t

,

S

t

r

a

t

e

g

i

c

M

a

r

k

e

t

i

n

g

.

P

r

e

v

i

o

u

s

l

y

,

s

h

e

w

o

r

k

e

d

a

t

J

o

h

n

s

o

n

&

J

o

h

n

s

o

n

,

T

h

e

C

o

c

a

-

C

o

l

a

C

o

m

p

a

n

y

a

n

d

C

i

t

i

b

a

n

k

,

N

.

A

.

M

s

.

S

o

r

i

a

n

o

c

u

r

r

e

n

t

l

y

s

e

r

v

e

s

a

s

a

m

e

m

b

e

r

o

f

t

h

e

b

o

a

r

d

o

f

d

i

r

e

c

t

o

r

s

o

f

S

c

i

o

n

H

e

a

l

t

h

.

Since 2025
Age 54
Tenure 1 yr

Also at Baxter International Inc.

AH Andrew P. Hider President & CEO BS Brent Shafer Non-Executive Chair of the Board WI William A. Ampofo II Director JC Jeffrey A. Craig Director MM Michael R. McDonnell Director PM Patricia B. Morrison Director

Roles

Organization Role Dates Details
Baxter International Inc. Group President, Infusion Therapies & Technologies (ITT) and Pharmaceuticals 2025–present Current role
Baxter International Inc. President, Infusion Therapies & Technologies 2023 to 2025
Becton, Dickinson and Company Global Vice President and General Manager, Microbiology 2020 to 2023 Earlier roles included U.S. VP and GM, Diabetes Care; SVP, Global Marketing and Strategy; and VP, Strategic Marketing.
Johnson & Johnson; The Coca-Cola Company; Citibank, N.A. Prior roles
Becton Dickinson (BD) Global VP/General Manager, Microbiology
Johnson & Johnson Marketing, commercial and business leadership roles

External roles

Organization Role Dates
ScionHealth Director present
ScionHealth Board Member

Related

Source: Baxter International Inc. SEC filings and official company website

See how VectorShift works for your firm

Request Demo